Circulation, Vol 65, 1315-1320, Copyright © 1982 by American Heart Association
VS Banka, H Yamazaki, JB Agarwal, MM Bodenheimer and RH Helfant
The effects of digitalis (ouabain infusion, priming dose of 10
micrograms/kg/min followed by 2.0 micrograms/kg/min) on subepicardial and
subendocardial ischemic dysfunction during partial occlusion (59.4%
reduction in coronary flow) and total coronary occlusion were evaluated in
14 dogs using pairs of ultrasonic crystals implanted in the epicardial and
endocardial layers. After 30 minutes of partial coronary occlusion,
systolic shortening in the ischemic zone decreased from 12.4 +/- 2.9% to
-0.4 +/- 0.9% (p less than 0.001) in the epicardium and from 18.9 +/- 3.1%
to -1.0 +/- 1.1% (p less than 0.001) in the endocardium. Ouabain infusion
increased the systolic shortening from - 0.4 +/- 0.9% to 10.6 +/- 3.1% (p
less than 0.001) in the epicardium and from -1.0 +/- 1.1% to 17.2 +/- 3.4%
(p less than 0.001) in the endocardium. The end-diastolic length did not
change. In contrast, after 30 minutes of total coronary occlusion, systolic
shortening in both epicardial and endocardial layers was replaced by
systolic lengthening and remained unaffected by ouabain infusion in both
layers. Systolic shortening in the nonischemic epicardial and endocardial
layers increased consistently. We conclude that ouabain improves the
contractile function of both ischemic epicardial and endocardial layers
layers after partial coronary occlusion and does not worsen subendocardial
ischemic dysfunction. After total coronary occlusion, however, the
contraction of the ischemic zone is unaffected by ouabain.
ARTICLES
Effects of digitalis on subendocardial and subepicardial dysfunction during acute ischemia
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1982 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |